Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?
{{output}}
Purpose of review: This review highlights the latest findings regarding hypocitraturia in autosomal dominant polycystic kidney disease (ADPKD), from both experimental and clinical studies, exploring the underlying pathophysiology... ...